437 related articles for article (PubMed ID: 27508514)
1. Emerging Roles for Noncanonical NF-κB Signaling in the Modulation of Inflammatory Bowel Disease Pathobiology.
McDaniel DK; Eden K; Ringel VM; Allen IC
Inflamm Bowel Dis; 2016 Sep; 22(9):2265-79. PubMed ID: 27508514
[TBL] [Abstract][Full Text] [Related]
2. An epithelial
Chawla M; Mukherjee T; Deka A; Chatterjee B; Sarkar UA; Singh AK; Kedia S; Lum J; Dhillon MK; Banoth B; Biswas SK; Ahuja V; Basak S
Proc Natl Acad Sci U S A; 2021 Jun; 118(25):. PubMed ID: 34155144
[TBL] [Abstract][Full Text] [Related]
3. Noncanonical NF-κB Signaling Upregulation in Inflammatory Bowel Disease Patients is Associated With Loss of Response to Anti-TNF Agents.
Nguyen VQ; Eden K; Morrison HA; Sammons MB; Knight KK; Sorrentino S; Brock RM; Grider DJ; Allen IC; Sorrentino D
Front Pharmacol; 2021; 12():655887. PubMed ID: 34177575
[No Abstract] [Full Text] [Related]
4. IL-1beta-induced increase in intestinal epithelial tight junction permeability is mediated by MEKK-1 activation of canonical NF-kappaB pathway.
Al-Sadi R; Ye D; Said HM; Ma TY
Am J Pathol; 2010 Nov; 177(5):2310-22. PubMed ID: 21048223
[TBL] [Abstract][Full Text] [Related]
5. 6-(methylsulfinyl)hexyl isothiocyanate (6-MITC) from Wasabia japonica alleviates inflammatory bowel disease (IBD) by potential inhibition of glycogen synthase kinase 3 beta (GSK-3β).
Lohning A; Kidachi Y; Kamiie K; Sasaki K; Ryoyama K; Yamaguchi H
Eur J Med Chem; 2021 Apr; 216():113250. PubMed ID: 33691258
[TBL] [Abstract][Full Text] [Related]
6. Late-phase synthesis of IκBα insulates the TLR4-activated canonical NF-κB pathway from noncanonical NF-κB signaling in macrophages.
Chatterjee B; Banoth B; Mukherjee T; Taye N; Vijayaragavan B; Chattopadhyay S; Gomes J; Basak S
Sci Signal; 2016 Dec; 9(457):ra120. PubMed ID: 27923915
[TBL] [Abstract][Full Text] [Related]
7. Immune Differentiation Regulator p100 Tunes NF-κB Responses to TNF.
Chatterjee B; Roy P; Sarkar UA; Zhao M; Ratra Y; Singh A; Chawla M; De S; Gomes J; Sen R; Basak S
Front Immunol; 2019; 10():997. PubMed ID: 31134075
[TBL] [Abstract][Full Text] [Related]
8. [Noncanonical NF-κB pathway and hematological malignancies].
Wang WJ; Sun AN; Guo F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1069-73. PubMed ID: 20723331
[TBL] [Abstract][Full Text] [Related]
9. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
[TBL] [Abstract][Full Text] [Related]
10. Maximal adamantyl-substituted retinoid-related molecule-induced apoptosis requires NF-κB noncanonical and canonical pathway activation.
Farhana L; Dawson MI; Murshed F; Fontana JA
Cell Death Differ; 2011 Jan; 18(1):164-73. PubMed ID: 20671747
[TBL] [Abstract][Full Text] [Related]
11. S-Alk(en)ylmercaptocysteine suppresses LPS-induced pro-inflammatory responses in murine macrophages through inhibition of NF-κB pathway and modulation of thiol redox status.
Tocmo R; Parkin K
Free Radic Biol Med; 2018 Dec; 129():548-558. PubMed ID: 30342185
[TBL] [Abstract][Full Text] [Related]
12. TNF-α Modulation of Intestinal Tight Junction Permeability Is Mediated by NIK/IKK-α Axis Activation of the Canonical NF-κB Pathway.
Al-Sadi R; Guo S; Ye D; Rawat M; Ma TY
Am J Pathol; 2016 May; 186(5):1151-65. PubMed ID: 26948423
[TBL] [Abstract][Full Text] [Related]
13. Noncanonical NF-κB signaling is limited by classical NF-κB activity.
Gray CM; Remouchamps C; McCorkell KA; Solt LA; Dejardin E; Orange JS; May MJ
Sci Signal; 2014 Feb; 7(311):ra13. PubMed ID: 24497610
[TBL] [Abstract][Full Text] [Related]
14. IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts.
House CD; Grajales V; Ozaki M; Jordan E; Wubneh H; Kimble DC; James JM; Kim MK; Annunziata CM
BMC Cancer; 2018 May; 18(1):595. PubMed ID: 29801480
[TBL] [Abstract][Full Text] [Related]
15. Noncanonical NF-κB activation and SDF-1 expression in human endothelial cells.
McCorkell KA; May MJ
Methods Mol Biol; 2015; 1280():155-80. PubMed ID: 25736748
[TBL] [Abstract][Full Text] [Related]
16. A fourth IkappaB protein within the NF-kappaB signaling module.
Basak S; Kim H; Kearns JD; Tergaonkar V; O'Dea E; Werner SL; Benedict CA; Ware CF; Ghosh G; Verma IM; Hoffmann A
Cell; 2007 Jan; 128(2):369-81. PubMed ID: 17254973
[TBL] [Abstract][Full Text] [Related]
17. Flavokawain B inhibits NF-κB inflammatory signaling pathway activation in inflammatory bowel disease by targeting TLR2.
Chen Y; Jin T; Zhang M; Hong B; Jin B; Hu C; Wang J; Chen Y; Zhang L; Wang Y; Huang L
Toxicol Appl Pharmacol; 2024 May; 486():116922. PubMed ID: 38583725
[TBL] [Abstract][Full Text] [Related]
18. A TNF-p100 pathway subverts noncanonical NF-κB signaling in inflamed secondary lymphoid organs.
Mukherjee T; Chatterjee B; Dhar A; Bais SS; Chawla M; Roy P; George A; Bal V; Rath S; Basak S
EMBO J; 2017 Dec; 36(23):3501-3516. PubMed ID: 29061763
[TBL] [Abstract][Full Text] [Related]
19. The NF-κB signaling system in the immunopathogenesis of inflammatory bowel disease.
Mukherjee T; Kumar N; Chawla M; Philpott DJ; Basak S
Sci Signal; 2024 Jan; 17(818):eadh1641. PubMed ID: 38194476
[TBL] [Abstract][Full Text] [Related]
20. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
